Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (121-130 of 833) with videos related to

Pageof 84
Sort By:
The American Journal of Medicine|July 1, 1984
Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosusA McCoubrey-Hoyer, T B Okarma, H R Holman
Diabetes Care|February 1, 1996
Frequency of hypoglycemic episodes during intensive therapy with human insulinR C Tubner, C A Cull, R R Holman
Future Medicinal Chemistry|December 16, 2014
The potential of 12/15-lipoxygenase inhibitors in stroke therapyKlaus van Leyen, Theodore R Holman, David J Maloney
Addiction (Abingdon, England)|April 24, 2013
Psychological predictors of male smokeless tobacco use initiation and cessation: a 16-year longitudinal studyLeela R Holman, Jonathan B Bricker, Bryan A Comstock
Arthritis and Rheumatism|April 1, 1993
Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costsK R Lorig, P D Mazonson, H R Holman
British Medical Journal|January 19, 1980
Survival in sinoatrial disorder (sick-sinus syndrome)D B Shaw, R R Holman, J I Gowers
The Journal of Experimental Medicine|September 1, 1973
Transformation of histocompatibility immunogen into a tolerogenS H Nimelstein, A R Hotti, H R Holman
Biochemistry|May 18, 1993
Purification and characterization of VanR and the cytosolic domain of VanS: a two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147G D Wright, T R Holman, C T Walsh
Diabetes Research and Clinical Practice|July 28, 2017
Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)J C Levy, M J Davies, R R Holman, et al.
The New England Journal of Medicine|December 21, 2017
Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 DiabetesRury R Holman, M Angelyn Bethel, Adrian F Hernandez
Pageof 84

Showing results (121-130 of 833) with videos related to

Sort By:
Pageof 84
The American Journal of Medicine|July 1, 1984
Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosusA McCoubrey-Hoyer, T B Okarma, H R Holman
Diabetes Care|February 1, 1996
Frequency of hypoglycemic episodes during intensive therapy with human insulinR C Tubner, C A Cull, R R Holman
Future Medicinal Chemistry|December 16, 2014
The potential of 12/15-lipoxygenase inhibitors in stroke therapyKlaus van Leyen, Theodore R Holman, David J Maloney
Addiction (Abingdon, England)|April 24, 2013
Psychological predictors of male smokeless tobacco use initiation and cessation: a 16-year longitudinal studyLeela R Holman, Jonathan B Bricker, Bryan A Comstock
Arthritis and Rheumatism|April 1, 1993
Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costsK R Lorig, P D Mazonson, H R Holman
British Medical Journal|January 19, 1980
Survival in sinoatrial disorder (sick-sinus syndrome)D B Shaw, R R Holman, J I Gowers
The Journal of Experimental Medicine|September 1, 1973
Transformation of histocompatibility immunogen into a tolerogenS H Nimelstein, A R Hotti, H R Holman
Biochemistry|May 18, 1993
Purification and characterization of VanR and the cytosolic domain of VanS: a two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147G D Wright, T R Holman, C T Walsh
Diabetes Research and Clinical Practice|July 28, 2017
Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)J C Levy, M J Davies, R R Holman, et al.
The New England Journal of Medicine|December 21, 2017
Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 DiabetesRury R Holman, M Angelyn Bethel, Adrian F Hernandez
Pageof 84